Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 22805051)

Published in J Eur Acad Dermatol Venereol on August 01, 2012

Authors

J Ring1, A Alomar, T Bieber, M Deleuran, A Fink-Wagner, C Gelmetti, U Gieler, J Lipozencic, T Luger, A P Oranje, T Schäfer, T Schwennesen, S Seidenari, D Simon, S Ständer, G Stingl, S Szalai, J C Szepietowski, A Taïeb, T Werfel, A Wollenberg, U Darsow, European Dermatology Forum (EDF), European Academy of Dermatology and Venereology (EADV), European Federation of Allergy (EFA), European Task Force on Atopic Dermatitis (ETFAD), European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN)

Author Affiliations

1: Department of Dermatology and Allergy Biederstein, Christine Kühne-Center for Allergy Research and Education, Technische Universität München, Munich, Germany. johannes.ring@lrz.tum.de

Articles citing this

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol (2014) 2.09

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol (2013) 1.57

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol (2014) 1.32

Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol (2014) 0.98

Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res (2014) 0.88

Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy (2014) 0.87

Long term treatment concepts and proactive therapy for atopic eczema. Ann Dermatol (2012) 0.86

Mapping systematic reviews on atopic eczema--an essential resource for dermatology professionals and researchers. PLoS One (2013) 0.84

Difficult to control atopic dermatitis. World Allergy Organ J (2013) 0.84

Adult onset atopic dermatitis: Under-recognized or under-reported? Indian Dermatol Online J (2013) 0.84

Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis. Clin Cosmet Investig Dermatol (2013) 0.83

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis. Chin Med J (Engl) (2016) 0.83

Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol (2015) 0.81

The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int (2014) 0.81

Disease awareness and management behavior of patients with atopic dermatitis: a questionnaire survey of 313 patients. Ann Dermatol (2015) 0.80

Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol Alergol (2013) 0.79

Barrier function and microbiotic dysbiosis in atopic dermatitis. Clin Cosmet Investig Dermatol (2015) 0.79

A Comprehensive Review of the Treatment of Atopic Eczema. Allergy Asthma Immunol Res (2016) 0.78

Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr (2016) 0.78

Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment. Ann Dermatol (2015) 0.78

Impact of interactive web-based education with mobile and email-based support of general practitioners on treatment and referral patterns of patients with atopic dermatitis: randomized controlled trial. J Med Internet Res (2012) 0.77

Evidence - based pharmacological treatment of atopic dermatitis: an expert opinion and new expectations. Indian J Dermatol (2014) 0.76

Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment. Ann Dermatol (2015) 0.76

Chitosan Coated Textiles May Improve Atopic Dermatitis Severity by Modulating Skin Staphylococcal Profile: A Randomized Controlled Trial. PLoS One (2015) 0.76

Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis. Pediatr Dermatol (2016) 0.76

Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation. Oncotarget (2016) 0.76

[Not Available]. J Clin Aesthet Dermatol (2015) 0.75

Psychiatry outpatient visits by atopic dermatitis patients varying in the complexity of their prescriptions: A nationwide cohort study conducted from 2005 to 2013. Medicine (Baltimore) (2016) 0.75

Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis. An Bras Dermatol (2014) 0.75

Luffa cylindrica suppresses development of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in Nc/Nga mice. Pharm Biol (2014) 0.75

Food Allergy in Atopic Dermatitis. Indian J Dermatol (2016) 0.75

Psoriasis and Atopic Dermatitis. Dermatol Ther (Heidelb) (2017) 0.75

Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action. Int J Mol Sci (2017) 0.75

A review on the role of moisturizers for atopic dermatitis. Asia Pac Allergy (2016) 0.75

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department. Drugs Context (2017) 0.75

Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postepy Dermatol Alergol (2015) 0.75

Therapeutic management of anal eczema: an evidence-based review. Int J Clin Pract (2014) 0.75

S2k guideline on diagnosis and treatment of atopic dermatitis - short version. Allergo J Int (2016) 0.75

Efficacy and Tolerability of Steroid-Free, Over-the-Counter Treatment Formulations in Infants and Children With Atopic Dermatitis. J Dermatol Nurses Assoc (2015) 0.75

Child with atopic dermatitis. Ann Allergy Asthma Immunol (2015) 0.75

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial). Trials (2014) 0.75

Effects of Angelicae dahuricae Radix on 2, 4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in mice model. BMC Complement Altern Med (2017) 0.75

Prehydration is effective for rapid control of recalcitrant atopic dermatitis. Dermatitis (2014) 0.75

Gender Differences in Self-assessed Health-related Quality of Life in Children with Atopic Dermatitis. J Clin Aesthet Dermatol (2016) 0.75

The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis. Int J Mol Med (2017) 0.75

Commentary on ''dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation''. J Invest Dermatol (2014) 0.75

Stigmatization and self-perception in children with atopic dermatitis. Clin Cosmet Investig Dermatol (2016) 0.75

Systemic Treatment of Adult Atopic Dermatitis: A Review. Dermatol Ther (Heidelb) (2016) 0.75

Atopic Dermatitis Studies through In Vitro Models. Front Med (Lausanne) (2017) 0.75

Particular characteristics of atopic eczema in tropical environments. The Tropical Environment Control for Chronic Eczema and Molecular Assessment (TECCEMA) cohort study. An Bras Dermatol (2017) 0.75

Treatment of moderate-to-severe atopic eczema in adults within the UK: results of a national survey of dermatologists. Br J Dermatol (2016) 0.75

Gain-switched 311-nm Ti:Sapphire laser might be a potential treatment modality for atopic dermatitis. Lasers Med Sci (2016) 0.75

Articles by these authors

A physical map of 30,000 human genes. Science (1998) 12.43

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med (1993) 4.88

Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol (1978) 4.55

Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun (1998) 4.19

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97

Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest (1984) 3.86

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med (2001) 3.74

Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: two allelic variants of the peptide pheromone. J Bacteriol (1996) 3.72

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48

Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature (1983) 3.43

Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol (1987) 3.41

Infantile acute hemorrhagic edema of the skin: study of ten cases. J Am Acad Dermatol (1991) 3.33

Epidermal Langerhans cells bear Fc and C3 receptors. Nature (1977) 3.21

A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19

Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1998) 3.17

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet (2000) 2.85

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85

Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75

Itch: scratching more than the surface. QJM (2003) 2.75

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74

Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet (2001) 2.72

High-efficiency transformation of Streptococcus lactis protoplasts by plasmid DNA. Appl Environ Microbiol (1986) 2.68

Epidemiology of tension-type headache. JAMA (1998) 2.63

Pax: a murine multigene family of paired box-containing genes. Genomics (1991) 2.60

Origin and function of epidermal Langerhans cells. Immunol Rev (1980) 2.54

Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development (1990) 2.42

Chagas' disease. Clin Microbiol Rev (1992) 2.30

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension (1989) 2.29

Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28

Collodion baby: a follow-up study of 17 cases. J Eur Acad Dermatol Venereol (2002) 2.25

Timing fracture repair in patients with severe brain injury (Glasgow Coma Scale score <9) J Trauma (1998) 2.24

The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23

Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20

Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta. Development (1995) 2.20

Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol (1999) 2.19

Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol (2011) 2.19

Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J Immunol (1988) 2.17

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12

Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines. Science (1987) 2.12

Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest (1996) 2.10

Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol (1988) 2.09

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05

The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02

Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol (2010) 2.01

Maternal inhibition of hepatitis B surface antigen gene expression in transgenic mice correlates with de novo methylation. Nature (1987) 2.00

Medical consultation for migraine: results from the American Migraine Study. Headache (1998) 1.99

The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93

Detection of Ia antigens on Langerhans cells in guinea pig skin. J Immunol (1978) 1.90

A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol (1984) 1.90

Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med (1999) 1.89

Epidermal cells adhere preferentially to type IV (basement membrane) collagen. J Cell Biol (1979) 1.86

Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med (1994) 1.85

Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81

Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77

Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol (1999) 1.77

Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med (1992) 1.77

Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO J (1996) 1.76

HIV-related skin diseases. Lancet (1996) 1.76

Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75

Inflammatory familial palmoplantar keratoderma: Greither's disease? Dermatology (1992) 1.75

Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73

Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat (2004) 1.73

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72

Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. J Invest Dermatol (1978) 1.71

Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol (2006) 1.69

Constraint-induced movement therapy for focal hand dystonia in musicians. Lancet (1999) 1.69

A mouse gene homologous to the Drosophila gene caudal is expressed in epithelial cells from the embryonic intestine. Genes Dev (1988) 1.68

Congenital cutaneous defects as complications in surviving co-twins. Aplasia cutis congenita and neonatal volkmann ischemic contracture of the forearm. Arch Dermatol (1998) 1.67

Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia (1975) 1.63

Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis (2002) 1.63

Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol (2002) 1.62

Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol (1991) 1.60

Antigen presentation by murine epidermal langerhans cells and its alteration by ultraviolet B light. J Immunol (1981) 1.60

The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey. Br J Dermatol (2013) 1.60

Cytokine modulation of keratinocyte cytokines. J Invest Dermatol (1990) 1.59

Psychodermatological aspects of atopic dermatitis. Br J Dermatol (2014) 1.59

The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol (1995) 1.59

Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med (1990) 1.57

Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol (1998) 1.56

Long-term administration of pancuronium and pipecuronium in the intensive care unit. Anesth Analg (1994) 1.56

Contact sensitization in children. Pediatr Dermatol (1998) 1.55

Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55

BioMiner--modeling, analyzing, and visualizing biochemical pathways and networks. Bioinformatics (2002) 1.55

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55

Prospective association between food sensitization and food allergy: results of the LISA birth cohort study. Clin Exp Allergy (2009) 1.55

Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy (2006) 1.54